The India organoids market is on the cusp of a transformative era that will fundamentally redefine biomedical research and personalized medicine in the country. The convergence of advanced stem cell technologies, 3D bioprinting, artificial intelligence, and strategic collaborations is creating a new paradigm where organoids become integral to drug discovery, disease modeling, and regenerative...